These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8208315)
1. Location of primary and recurrent superficial bladder tumors and benefits of selective biopsies. Hanus M; Matousková M Neoplasma; 1994; 41(2):119-22. PubMed ID: 8208315 [TBL] [Abstract][Full Text] [Related]
2. [Significance of random biopsies of healthy mucosa in superficial bladder tumor]. Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385 [TBL] [Abstract][Full Text] [Related]
3. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A; Kumar R; Gupta NP Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358 [TBL] [Abstract][Full Text] [Related]
4. Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder? Guy L; Savareux L; Molinié V; Botto H; Boiteux JP; Lebret T Eur Urol; 2006 Sep; 50(3):516-20; discussion 520. PubMed ID: 16632184 [TBL] [Abstract][Full Text] [Related]
5. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer. Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912 [TBL] [Abstract][Full Text] [Related]
6. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer. Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903 [TBL] [Abstract][Full Text] [Related]
7. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer. Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T; Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414 [TBL] [Abstract][Full Text] [Related]
8. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer. Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171 [TBL] [Abstract][Full Text] [Related]
9. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings. Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520 [TBL] [Abstract][Full Text] [Related]
10. [Localization of primary and recurrent bladder tumors]. Samodai L; Kolozsy Z; Mohácsi L; Dauda G Orv Hetil; 1991 Jun; 132(26):1421-6. PubMed ID: 1870850 [TBL] [Abstract][Full Text] [Related]